Navigation Links
TCT 2010 to have significant impact on interventional cardiology practices and patient care
Date:7/20/2010

NEW YORK, NY JULY 20, 2010 TCT 2010 (Transcatheter Cardiovascular Therapeutics) will provide significant clinical research updates to technologies and practices in interventional cardiology that will directly affect patient care.

At TCT 2010 (September 21-25 in Washington, DC), late breaking data from clinical trials on the next generation of stents, interventional cardiology techniques, and the interactions and effectiveness of new medicines will shed light on the best ways to treat patients. Several hundred abstracts will also be presented on a variety of interesting topics including studies comparing various types of stents and assessing new techniques and technologies all designed to improve care for patients with cardiovascular disease.

"New catheter-based strategies, novel stents, and the effectiveness of various drugs used to treat heart disease are going to be among the major topics at TCT this year," said Gregg W. Stone, MD, Professor of Medicine at Columbia University College of Physicians and Surgeons, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Co-Director of the Medical Research and Education Division at the Cardiovascular Research Foundation. TCT is organized by the Cardiovascular Research Foundation.

This year, TCT will also provide a new program, "TCT in 3," designed specifically for the busy interventional practitioner, which features a concentrated curriculum in a shorter 3 day time frame from Thursday, September 23 through Saturday, September 25. Highlights include live cases, late breaking trials and practice management sessions.

And once again, the conference will feature specific tracks for Cardiac Surgeons and Nurses and Technologists. The Surgeons Course will provide instruction on percutaneous valve repair, hybrid (joint) surgical and interventional approaches to heart disease, percutaneous aortic aneurysm repair methods, with an in-depth course on advanced surgical techniques. The 19th Annual Nurse and Technologist Symposium will detail new trends and cath lab procedures essential for the allied health care professional.

In 2009, TCT was held for the first time in San Francisco, where it attracted record numbers of attendees. 99.4% of physician attendees surveyed stated that TCT increased their knowledge to improve their practice.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care
2. It's Snow Joke as UK Gas and Electricity Bills Hit Record Highs -- Energyhelpline Calls for “Significant” Price Cuts
3. Survey finds significant racial differences in lung cancer beliefs
4. Combined drug therapy to treat TB and HIV significantly improves survival
5. Smoking significantly increases risk of aneurysm in people with certain genes
6. New research shows innovative respiratory stress test can quickly detect significant coronary artery disease in a noninvasive setting
7. Studies Show Significant Increases of C. Difficile Infections (CDI)
8. Male Infertility Significantly Increases Risk of Prostate Cancer
9. Alzheimers Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law
10. Crack and cocaine use a significant HIV risk factor for teens
11. Cosmetic Peptides that Significantly Reduce Length and Depth of Wrinkles: Janet Sartin Introduces Advanced Anti-Wrinkle Peptide Serum for All Skin Types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, ... (iPS) cells and other difficult to transfect cells, announces its launch of the ... G9™ Gene Editing System is a complete system for culturing and transfecting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: